ATE220557T1 - Darmprotozoen-impfstoffe - Google Patents

Darmprotozoen-impfstoffe

Info

Publication number
ATE220557T1
ATE220557T1 AT93119126T AT93119126T ATE220557T1 AT E220557 T1 ATE220557 T1 AT E220557T1 AT 93119126 T AT93119126 T AT 93119126T AT 93119126 T AT93119126 T AT 93119126T AT E220557 T1 ATE220557 T1 AT E220557T1
Authority
AT
Austria
Prior art keywords
methods
vaccines
intestinal protozoa
protozoa
intestinal
Prior art date
Application number
AT93119126T
Other languages
English (en)
Inventor
Merle E Olson
Howard Ceri
Douglas W Morck
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of ATE220557T1 publication Critical patent/ATE220557T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93119126T 1992-12-04 1993-11-26 Darmprotozoen-impfstoffe ATE220557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98548992A 1992-12-04 1992-12-04
US08/156,618 US5512288A (en) 1992-12-04 1993-11-23 Giardia vaccine

Publications (1)

Publication Number Publication Date
ATE220557T1 true ATE220557T1 (de) 2002-08-15

Family

ID=26853351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93119126T ATE220557T1 (de) 1992-12-04 1993-11-26 Darmprotozoen-impfstoffe

Country Status (9)

Country Link
US (3) US5512288A (de)
EP (1) EP0600396B1 (de)
JP (2) JP3856345B2 (de)
AT (1) ATE220557T1 (de)
CA (1) CA2109977C (de)
DE (1) DE69332111T2 (de)
DK (1) DK0600396T3 (de)
ES (1) ES2177535T3 (de)
PT (1) PT600396E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549899A (en) * 1992-12-04 1996-08-27 University Technologies International, Inc. Giardia vaccine
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
AUPN353695A0 (en) * 1995-06-14 1995-07-06 Commonwealth Scientific And Industrial Research Organisation Immunogenic preparation and method for improving the productivity of ruminant animals
WO1997029120A1 (en) * 1996-02-05 1997-08-14 Sarco Research Corporation Limited Sarcocystine isolation
US20030235903A1 (en) * 2002-06-20 2003-12-25 University Technologies International, Inc. Propagation of cryptosporidium in cell culture
EP1725652A4 (de) * 2004-02-26 2007-08-08 Univ Murdoch Kulturverfahren für cryptosporidium
AT502702B1 (de) * 2005-05-12 2008-05-15 Veterinaermedizinische Uni Wie Verfahren zur herstellung und anwendung von protozoenkulturen
NZ604943A (en) * 2008-12-02 2014-08-29 Consejo Nac Invest Cient Tec Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
KR101631312B1 (ko) * 2014-06-16 2016-06-20 연세대학교 산학협력단 재조합 람블편모충 결합 면역글로블린 단백질을 포함하는 면역증강 조성물
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US10478493B2 (en) 2015-08-31 2019-11-19 Stolle Milk Biologics, Inc. Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
US4314992A (en) * 1978-11-08 1982-02-09 Bitakaramire Peter K Process for producing fascioliasis vaccine
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
EP0071705B1 (de) * 1981-05-21 1989-11-23 The Wellcome Foundation Limited Protozoen-Antigen
US4493825A (en) * 1982-10-05 1985-01-15 Iowa State University Research Foundation Purified and antigenically selective vaccines for domestic animals
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US4687666A (en) * 1985-02-19 1987-08-18 Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas Vaccine for Leishmaniasis
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
US5028694A (en) * 1985-12-03 1991-07-02 Solvay & Cie, S.A. Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
US5045313A (en) * 1989-07-07 1991-09-03 The University Of Kansas Vaccine for immunizing cats against toxoplasma oocyst shedding

Also Published As

Publication number Publication date
US6153191A (en) 2000-11-28
DE69332111T2 (de) 2003-02-27
JP2004137286A (ja) 2004-05-13
CA2109977A1 (en) 1994-06-05
ES2177535T3 (es) 2002-12-16
EP0600396B1 (de) 2002-07-17
CA2109977C (en) 2009-05-12
EP0600396A3 (de) 1995-07-12
DE69332111D1 (de) 2002-08-22
US5922329A (en) 1999-07-13
US5512288A (en) 1996-04-30
JP3856345B2 (ja) 2006-12-13
PT600396E (pt) 2002-12-31
DK0600396T3 (da) 2002-10-28
JPH0789872A (ja) 1995-04-04
EP0600396A2 (de) 1994-06-08

Similar Documents

Publication Publication Date Title
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
IL189629A0 (en) Compositions containing human ctla-4 antibodies
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
ATE220557T1 (de) Darmprotozoen-impfstoffe
NO874364D0 (no) Antivirus-immunoterapeutisk middel og fremstilling derav.
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
NL300401I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
YU174491A (sh) Vakcine
IL105119A0 (en) Immunoglobins and antigens for the treatment of staphylococcus infections,methods for the identification and preparation thereof and pharmaceutical compositions containing the same
EP0869801A4 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69426767D1 (de) Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ES2159287T3 (es) Peptidos hemorreguladores.
ATE283920T1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
DE69314022D1 (de) Derivate von 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranen
DK0684842T3 (da) Præparat til behandling af tumorer og immunisering af organismer over for tumorer
NO933628D0 (no) Fremgangsmaate og blanding for behandling av herpes-infeksjoner
MX9400210A (es) Tratamiento de infecciones virales.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee